Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

Aeluma, Inc. (Nasdaq: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, automotive, AI, defense and aerospace, communication, and quantum computing ...

Damon Inc., a manufacturer specializing in motorcycles and bicycle parts, currently trading at $0.01 per share after losing 99.12% year-to-date, received a notification from The Nasdaq Stock ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate NeoGenomics, Inc. before investing. In this article, we go over a few key ...

The proxy fight will come to a head at the annual shareholders meeting on May 14. Another Harley-Davidson Inc. investor has urged the ousting of three Harley board members and the firing of CEO ...

The basic problem Pot Inc. faces in the US is banking. Sale of weed and its various forms like gummies and even pot-laced soft drinks is estimated at between $40 billion and $60 billion ...

ServiceNow Inc (NYSE:NOW) reported its biggest Q1 ever for net new ACV, with subscription revenue growing 20% year over year in constant currency. The company achieved an operating margin of 31% ...

CapEx Guidance: Forecasted to exceed $10 billion for the year. Tesla Inc (NASDAQ:TSLA) is on track to launch fully autonomous rides in Austin by June, with plans to expand to other cities by the ...

Inc. (the “Company”) from the NYSE. Trading in the Company’s Class A common stock will be suspended immediately. NYSE Regulation has determined that the Company’s Class A common stock is ...

The transaction is expected to give Olin first-year adjusted EBITDA of $10 million to $15 million. Once fully integrated, the acquisition of Ammo is estimated to yield adjusted EBITDA of $40 ...

filed. 02/25/2025 Brief amici curiae of United States of Care, et al. filed. 02/25/2025 Brief amici curiae of Public Citizen, et al. filed. 02/25/2025 Brief amicus curiae of Gilead Sciences, Inc.